Search Results
Feb 12, 2026, 15:30 ET LA COMMISSION EUROPEENNE APPROUVE UPLIZNA® D'AMGEN DANS LE CADRE DU TRAITEMENT DE LA MYASTHÉNIE GRAVE GÉNÉRALISÉE
epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021;10(11):2235.Hehir MK, Silvestri NJ. Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology. Neurol Clin. 2018;36:253-260.
More news about: Amgen
Feb 12, 2026, 15:15 ET La Comisión Europea aprueba UPLIZNA® de Amgen para la miastenia gravis generalizada
epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021;10(11):2235.Hehir MK, Silvestri NJ. Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology. Neurol Clin. 2018;36:253-260.
More news about: Amgen
Feb 12, 2026, 09:00 ET EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS
epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021;10(11):2235.Hehir MK, Silvestri NJ. Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology. Neurol Clin. 2018;36:253-260.
More news about: Amgen
Feb 12, 2026, 07:30 ET Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
2021;161(1):113-121. 7. Vergote I, et al. J Clin Oncol. 2023;41(35):5400-5410. 8. Mirza
More news about: Karyopharm Therapeutics Inc.
Feb 10, 2026, 09:00 ET BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select®
& Spetzler, D. Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients. Clin Cancer Res. 2025 Jul 1;31(13):2710-2718. doi: 10.1158/1078-0432.CCR-24-3335.4. Coombs CC , Zehir A , Devlin SM , Kishtagari A , Syed
More news about: BillionToOne
Feb 05, 2026, 06:44 ET Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan
[3] Sabari, J., Lok, B., Laird, J. et al. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol 14, 549–561 (2017).[4]
More news about: Henlius
Feb 03, 2026, 08:57 ET NUTRAFOL INTRODUCES MEN 50+, THE FIRST AND ONLY HAIR GROWTH PRODUCT SPECIFICALLY FORMULATED FOR MEN 50+
& eCommerce Total US Online, 11/6/22-11/1/25 and US FDA-approved and OTC drugs through 12/31/25.[3] Stanworth et al., Clin Interv Aging. 2008[4] GoodQues Nutrafol TAM Study, 2025[5] Nutrafol data on file
More news about: NUTRAFOL
Feb 03, 2026, 08:00 ET AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Adults and Adolescents With Vitiligo
Birlea SA, Goldstein NB, Norris DA. Repigmentation through melanocyte regeneration in vitiligo. Dermatol Clin. 2017;35(2):205-218. doi:10.1016/j.det.2016.11.01510.
More news about: AbbVie
Feb 02, 2026, 09:17 ET Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances
sensors.Data on file. Abbott Diabetes Care, Inc.Eva Y. Wong, Lisa Kroon; Ultra-Rapid-Acting Insulins: How Fast Is Really Needed?. Clin Diabetes 1 October 2021; 39 (4): 415–423. https://doi.org/10.2337/cd20-0119§ Refers to SmartGuard™ feature. Individual results may varyThe
More news about: Medtronic plc
Feb 02, 2026, 08:00 ET Real-world head-to-head analysis shows 51% reduction in risk of death for patients with metastatic castration-sensitive prostate cancer treated with ERLEADA® (apalutamide) versus darolutamide without docetaxel through 24 months
Chesnaye NC, Stel VS, Tripepi G, et al. An introduction to inverse probability of treatment weighting in observational research. Clin Kidney J. 2021;15(1):14-20. doi:10.1093/ckj/sfab158
More news about: Johnson & Johnson
Jan 31, 2026, 07:22 ET JOHNNIE WALKER CÉLÈBRE LE PLUS GRAND WEEK-END DE LA MUSIQUE AVEC LE GO GO HIGHBALL
la ville - faisant du Go Go Highball la boisson incontournable des principaux labels, nominés et gagnants du secteur de la musique.En clin d'œil au style étincelant de Sabrina et au glamour du tapis rouge du week-end, Johnnie Walker a également créé une pochette Highball ornée de cristaux,
More news about: Johnnie Walker
Jan 30, 2026, 13:40 ET Galderma promove treinamentos e reforça compromisso com a educação continuada em estética injetável durante o CIOSP
February 2024, Paris, France 11. Weiss RA et al. Dermatol Surg. 2016 Jun;42(6):699-709 12. Di Gregorio C et al. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:681-690. 13. Talarico S et al. Dermatol Surg. 2015 Dec;41(12):1361-9. 14. Belmontesi
More news about: Galderma
Jan 29, 2026, 09:30 ET NFL Greats and Novartis Tackle Prostate Cancer Myths at Super Bowl LX: "Relax, It's a Blood Test"
Kratzer TB, Mazzitelli N, Star J, et al. Prostate cancer statistics, 2025. CA Cancer J Clin. 2025;75(6):485-497. doi:10.3322/caac.70028 4.
More news about: Novartis Pharmaceuticals Corporation
Jan 28, 2026, 06:08 ET Stellular Bio Announces Closing of Series 1 Financing
Wróbel-Dudzinska et al., J. Clin. Med. 2023, 12, 3126;
More news about: Stellular Bio
Jan 27, 2026, 08:29 ET /C O R R E C T I O N -- Orasis Pharmaceuticals/
al. Efficacy and Safety of CSF-1 (0.4% Pilocarpine Hydrochloride) in Presbyopia: Pooled Results of the NEAR Phase 3 Randomized, Clinical Trials. Clin Ther. 2024;46(2):104-113. doi:10.1016/j.clinthera.2023.12.005.Correction: The photo caption in the earlier version was incorrect.
More news about: Orasis Pharmaceuticals
Jan 26, 2026, 19:00 ET Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
fully human BCMA-targeting CAR-T cells, in patients with relapsed/refractory multiple myeloma: Updated results of phase 1b/2 study (FUMANBA-1). J. Clin. Oncol. 2023;41(16_suppl):8025-8025.
More news about: Innovent Biologics
Jan 22, 2026, 05:00 ET New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand
Antonio, Texas.7. Saura C, et al. J Clin Oncol 2020;38(27):3138-3149.8. Saura C, et al. J Clin Oncol 2019;37 (suppl; abstr.1002).9.
More news about: Specialised Therapeutics
Jan 22, 2026, 03:02 ET Starlight Investments annonce l'achèvement d'un important projet de construction locative dans le Grand Manchester
l'énergie des médias et des industries créatives qui font la réputation de la région. Il s'aligne sur la façade rose-or du bâtiment et constitue un clin d'œil aux activités dynamiques de MediaCity. Le projet est construit par X1, un important promoteur immobilier britannique."La célébration de
More news about: Starlight Investments
Jan 19, 2026, 16:11 ET Ano novo, pele nova: quais tratamentos você deve investir agora para colher resultados ao longo do ano
February 2024, Paris, France 9. Weiss RA et al. Dermatol Surg. 2016 Jun;42(6):699-709 10. Di Gregorio C et al. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:681-690. 11. Talarico S et al. Dermatol Surg. 2015 Dec;41(12):1361-9. 12.
More news about: Galderma
Jan 19, 2026, 01:43 ET W. LUNABELLA élève la K-Beauty : Lancement du premier "centre de solutions de beauté totale" dans l'emblématique Marais à Paris
L'éclat d'une mariée réimaginéLe "W" de W. LUNABELLA est un clin d'œil au "mariage", qui résume la vision inébranlable de la directrice générale Yumi : d'étendre le teint parfait et convoité, autrefois réservé aux
More news about: LUNABELLA
Jan 16, 2026, 08:00 ET New clinical data highlights CAPLYTA® (lumateperone) as a promising option for achieving remission in adults with major depressive disorder
D, Ghelerter I, et al. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J Clin Psychiatry. 2021;82(2):20m13699. doi:10.4088/JCP.20m13699Martin M. Lumateperone as Adjunctive Therapy in Patients with Major Depressive
More news about: Johnson & Johnson
Jan 16, 2026, 06:49 ET Sobi Receives European Commission Approval for Aspaveli® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
2019;15(3):129-143.Servais A, et al. Kidney Int. 2012;82(4):454-464.Zand L, et al. J Am Soc Nephrol. 2014;25(5):1110-1117.Tarragón, B, et al. Clin J Am Soc Nephrol 2024; 19(8)1005-1015.Data on file using literature consensus.Fakhouri F, et al. N Engl J Med 2025;393:2210-2220This
More news about: Swedish Orphan Biovitrum AB
Jan 15, 2026, 09:00 ET Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect
experience leading high-performance health care and consumer services companies; most recently as Chief Financial Officer and Chief Operating Officer of Clin-Path Associates/Pathology Specialists of Arizona. She also has deep knowledge of the Sonora Quest, LSA and Banner Health governance models, having previously
More news about: Sonora Quest Laboratories
Jan 15, 2026, 00:29 ET Merz Aesthetics® 委任韓國女星宋慧喬為 BELOTERO® 亞太區品牌大使 引領仿生透明質酸療程 宣揚細節成就自然美
Vandeputte J. J Clin Aesthet Dermatol. 2018 Dec;11(12):30-39.[17] Corduff N, et al. A New Way of Classifying Hyaluronic Acid Fillers: The AART Classification. Clin Cosmet Investig
More news about: Merz Aesthetics®
Jan 13, 2026, 09:22 ET This Year Adopt Brain-boosting Habits
of dietary choline intake with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr. 2019 Dec 1;110(6):1416-1423. doi: 10.1093/ajcn/nqz148. PMID:
More news about: The Peanut Institute